| Date Filed | Type | Description |
| 08/17/2023 |
4
| CARLSON CAPITAL L P (10% Owner) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 215,000 shares
@ $0.4374, valued at
$94k
Sold 1,000 shares
@ $0.3916, valued at
$391.6 |
|
| 08/17/2023 |
3
| CARLSON CAPITAL L P (10% Owner) has filed a Form 3 on TFF Pharmaceuticals, Inc. |
| 08/15/2023 |
4
| Weisman Harlan F (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $0.25, valued at
$150k
|
|
| 08/15/2023 |
4
| ROCAMBOLI STEPHEN (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0.25, valued at
$5k
|
|
| 08/15/2023 |
4
| Roberts Brandi (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0.25, valued at
$5k
|
|
| 08/15/2023 |
4
| COLEMAN KIRK ALLEN (CFO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0.25, valued at
$5k
|
|
| 08/15/2023 |
4
| MILLS ROBERT S (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 40,000 shares
@ $0.25, valued at
$10k
|
|
| 08/15/2023 |
4
| Mikhak Zamaneh (Chief Medical Officer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 120,000 shares
@ $0.25, valued at
$30k
|
|
| 03/24/2023 |
4
| COLEMAN KIRK ALLEN (CFO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.8, valued at
$80k
|
|
| 03/13/2023 |
4
| ROCAMBOLI STEPHEN (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 13,000 shares
@ $0.8025, valued at
$10.4k
|
|
| 03/13/2023 |
4
| COLEMAN KIRK ALLEN (CFO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 12,000 shares
@ $0.7881, valued at
$9.5k
|
|
| 03/13/2023 |
4
| Weisman Harlan F (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 150,000 shares
@ $0.8789, valued at
$131.8k
|
|
| 03/13/2023 |
4
| Mikhak Zamaneh (Chief Medical Officer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $0.82, valued at
$12.3k
|
|
| 01/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| THURMAN RANDY H (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 40,255 shares
@ $4.29, valued at
$172.7k
Exercised 40,255 options to buy
@ $2.5, valued at
$100.6k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Fletcher Aaron G.L. (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 85,000 shares
@ $4.86, valued at
$413.1k
Bought 24,600 shares
@ $5.08, valued at
$125k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Fletcher Aaron G.L. (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 500,000 shares
@ $6.43, valued at
$3.2M
Bought 42,000 shares
@ $6.89, valued at
$289.4k
|
|
| 09/24/2021 |
4
| CANO CHRISTOPHER (COO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 43,000 options to buy
@ $7.93, valued at
$341k
|
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| COLEMAN KIRK ALLEN (CFO, Secretary and Treasurer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $7.3, valued at
$7.3k
|
|
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|